Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

2-DAY HEXO DEADLINE & UPDATE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages HEXO Corp. (HEXO) Investors to Contact Firm; Application Deadline Approaching

SAN FRANCISCO, CA / ACCESSWIRE / January 25, 2020 / Hagens Berman urges investors in HEXO Corp. (NYSE:HEXO) who have suffered losses in excess of $500,000 to submit their losses now to learn if they qualify to recover their investment losses. Hagens Berman has filed a class action complaint against HEXO and its senior executives and only two days remain until the Jan. 27, 2020 lead plaintiff application deadline.

Class Period: Jan. 25, 2019 - Nov. 15, 2019

Lead Plaintiff Deadline: Jan. 27, 2020

Sign Up Now: www.hbsslaw.com/investor-fraud/HEXO

Contact An Attorney Immediately: HEXO@hbsslaw.com

844-916-0895

Hagens Berman's HEXO Securities Class Action:

According to the detailed Complaint filed by Hagens Berman, Defendants failed to disclose to investors that: (1) HEXO's reported inventory was misstated due to its failure to write down or write off obsolete product; (2) HEXO was engaging in channel-stuffing to inflate its revenue figures; and (3) HEXO was cultivating unlicensed cannabis at its facilities.

The truth emerged through a series of disclosures occurring between Oct. 4, 2019 and Nov. 15, 2019, when the Company announced it was producing cannabis in a section of its Niagara facility that was not properly licensed with Health Canada.

As a result of these disclosures, the value of HEXO stock has consistently decreased, damaging investors.

On Jan. 2, 2020, the Company restated its FY-2019 annual financial statements and Q-1 FY 2020 interim financial statements. Notably, the Company increased its annual impairment loss on inventory by about 14% and disclosed material weaknesses in internal controls over financial reporting.

On Jan. 17, 2020, the Company's questionable accounting practices came into focus again, when MarketWatch published a report challenging the Company's employee-options accounting. MarketWatch reported that since June 2017, the Company has been incorrectly tabulating the remaining lifetime weighted average of its employee stock options, potentially violating International Financial Reporting Standards.

"We're focused on investors' losses and proving Defendants knowingly provided false financial information to the market," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you purchased HEXO common stock during the Class Period and suffered significant losses, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding HEXO should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email HEXO@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes is located at hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP



View source version on accesswire.com:
https://www.accesswire.com/574081/2-DAY-HEXO-DEADLINE-UPDATE-ALERT-HAGENS-BERMAN-NATIONAL-TRIAL-ATTORNEYS-Encourages-HEXO-Corp-HEXO-Investors-to-Contact-Firm-Application-Deadline-Approaching



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today